title: Hepatitis C virus infection in end stage renal disease and after kidney transplant.
authors.affiliation: Multivisceral Transplant Unit, Department of Surgery, Oncology, and Gastroenterology, Padua University Hospital, Padua, Italy.
authors.forename: Kryssia Isabel
authors.initials: KI
authors.lastname: Rodriguez-Castro
authors.affiliation: Department of Food Sciences, University of Naples "Federico II", Naples, Italy.
authors.forename: Filomena
authors.initials: F
authors.lastname: Morisco
authors.affiliation: Unit of Kidney and Pancreas Transplantation, Department of Surgery, Oncology, and Gastroenterology, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Rigotti
authors.affiliation: Department of Pathology, Padua University Hospital, Padua, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Rugge
authors.affiliation: Multivisceral Transplant Unit, Department of Surgery, Oncology, and Gastroenterology, Padua University Hospital, Padua, Italy.burra@unipd.it.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Burra
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D005838:Genotype; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics / Q000472:pathogenicity; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007676:Kidney Failure, Chronic / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D016030:Kidney Transplantation / Q000009:adverse effects; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D006435:Renal Dialysis / Q000009:adverse effects*; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load; D014775:Virus Activation / Q000187:drug effects
chemical_list: D000998:Antiviral Agents; D015415:Biomarkers; D007166:Immunosuppressive Agents; D012367:RNA, Viral